Medazol

Metronidazole, the active ingredient in Medazol, is a nitroimidazole presented as an oral tablet for oral use. It treats a range of bacterial and protozoal infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Medazol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metazol (metronidazole) is employed against anaerobic bacteria and certain protozoa across several clinical conditions.

- Bacterial vaginosis: eliminates the anaerobic flora causing vaginal discharge and odor. - Trichomoniasis: eradicates Trichomonas vaginalis, relieving itching and discharge. - Amoebiasis: clears intestinal Entamoeba histolytica infection and associated dysentery. - Giardiasis: removes Giardia lamblia parasites, reducing diarrhea and malabsorption. - Anaerobic bacterial infections: treats intra‑abdominal, pelvic and skin‑soft tissue infections caused by anaerobes. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile, aiding resolution of colitis.

Metazol may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Diarrhea: loose stools, often self‑limiting. - Headache: mild to moderate headache. - Abdominal pain: cramping or discomfort. - Dark urine: harmless discoloration of urine.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate care. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: rash, itching, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: severe skin blistering. - Hepatotoxicity: elevated liver enzymes or jaundice. - Hematologic abnormalities: neutropenia or thrombocytopenia.

Before prescribing Metazol, clinicians should consider several safety aspects.

- Pregnancy: use only if clearly needed; discuss risks with a healthcare provider. - Alcohol consumption: avoid alcohol due to a disulfiram‑like reaction. - Liver disease: monitor liver function; dose adjustment may be required. - Renal impairment: assess kidney function; dosage may need modification. - Drug interactions: review all concomitant medications for potential interactions. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Metazol can interact with several medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Disulfiram: may cause severe flushing and hypotension. - Warfarin: increased anticoagulant effect, raising bleeding risk. - Lithium: elevated lithium concentrations, risking toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma levels. - Oral contraceptives: possible reduction in contraceptive effectiveness. - Phenytoin: may lower metronidazole concentrations, reducing efficacy.